Joachim Wolf
Overview
Explore the profile of Joachim Wolf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wolf J, Niggemann P, Schaefer N, Tollens N, Rittmann M, Martins Dos Santos M, et al.
HNO
. 2025 Mar;
PMID: 40069396
Background: Retropharyngeal calcific tendinitis is an aseptic inflammation of the longus cervicis muscle. This rare acute pain disorder of the neck region is a prognostically benign condition compared to neurological...
2.
Maier A, Kettemann D, Weyen U, Grehl T, Schulte P, Steinbach R, et al.
Sci Rep
. 2025 Mar;
15(1):7360.
PMID: 40025240
In patients with amyotrophic lateral sclerosis (ALS), mechanical insufflation-exsufflation (MI-E) addresses cough deficiency to achieve major therapeutic goals: improving costal muscle and joint function, reducing atelectasis through insufflation, and clearing...
3.
Meyer T, Schumann P, Grehl T, Weyen U, Petri S, Rodiger A, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2024 Sep;
26(1-2):162-171.
PMID: 39268612
Objective: To report the frequency of pathogenic gene variants in a screening program in amyotrophic lateral sclerosis (ALS), and the clinical practice of transition to an expanded access program (EAP)...
4.
Linse K, Weber C, Reilich P, Schoberl F, Boentert M, Petri S, et al.
Neurol Res Pract
. 2024 Jul;
6(1):34.
PMID: 38961496
Introduction: Amyotrophic lateral sclerosis (ALS) is an inevitably fatal condition that leads to a progressive loss of physical functioning, which results in a high psychosocial burden and organizational challenges related...
5.
Wolf J, Niggemann P, Schaefer N, Tollens N, Rittmann M, Martins Dos Santos M, et al.
Schmerz
. 2023 Jul;
PMID: 37405523
Background: Retropharyngeal calcific tendinitis is an aseptic inflammation of the longus cervicis muscle. This rare acute pain disorder of the neck region is a prognostically benign condition compared to neurological...
6.
Heinrich F, Cordts I, GuNTHER R, Stolte B, Zeller D, Schroter C, et al.
J Neurol
. 2023 Jun;
270(10):4922-4938.
PMID: 37356024
Background And Objectives: Motor Neuron Diseases (MND) are rare diseases but have a high impact on affected individuals and society. This study aims to perform an economic evaluation of MND...
7.
Ruf W, Boros M, Freischmidt A, Brenner D, Grozdanov V, de Meirelles J, et al.
Brain Commun
. 2023 May;
5(3):fcad152.
PMID: 37223130
Therapy of motoneuron diseases entered a new phase with the use of intrathecal antisense oligonucleotide therapies treating patients with specific gene mutations predominantly in the context of familial amyotrophic lateral...
8.
Wiesenfarth M, Gunther K, Muller K, Witzel S, Weiland U, Mayer K, et al.
Brain Commun
. 2023 Apr;
5(2):fcad087.
PMID: 37006326
An expansion of the GGGGCC hexanucleotide in the non-coding region of represents the most common cause of familial amyotrophic lateral sclerosis. The objective was to describe and analyse the clinical...
9.
Nuzhat N, Van Schil K, Liakopoulos S, Bauwens M, Duenas Rey A, Kaseberg S, et al.
J Clin Invest
. 2023 Mar;
133(8).
PMID: 36862503
Defects in primary or motile cilia result in a variety of human pathologies, and retinal degeneration is frequently associated with these so-called ciliopathies. We found that homozygosity for a truncating...
10.
Yilmaz R, Grehl T, Eckrich L, Marschalkowski I, Weishaupt K, Valkadinov I, et al.
Amyotroph Lateral Scler Frontotemporal Degener
. 2023 Jan;
24(5-6):414-419.
PMID: 36650645
ALS patients with a negative family history (sporadic ALS, SALS) represent more than 90% of all ALS cases. In light of the gene-specific therapies that are currently in development for...